✦ LIBER ✦

4 High dose DES-P in metastatic prostate cancer-basis for a multimodal therapy?

✍ Scribed by U. Dunzendorfer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multimodal treatment approach includin

✍ Reichle, A; Bolder, U; Bataille, F; Messmann, H; Wagner, H; Zaiss, M; Wild, P; H 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Iridium 192 high-dose-rate brachytherapy

✍ R. Paul; R. Hofmann; J. U. Schwarzer; R. Stepan; H. J. Feldmann; P. Kneschaurek; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 666 KB

Is Hormone Therapy a Protective Factor f

✍ Almudena Zapatero; Feliciano García-Vicente; David Sevillano; Carmen Martín de V 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Four-cycle high-dose therapy with hemato

✍ Wendy W. Hu; Robert S. Negrin; Keith Stockerl-Goldstein; Laura J. Johnston; Judi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

High-dose, single-agent irinotecan as fi

✍ M. Ychou; J. Raoul; F. Desseigne; C. Borel; F. Caroli-Bosc; J. Jacob; J. Seitz; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 279 KB

Trends and Racial Differences in the Use

✍ April P. Carson; Daniel L. Howard; William R. Carpenter; Yhenneko J. Taylor; Sha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 225 KB